Gaithersburg, MD, United States of America

Anand Swaroop

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (2009 - 2010)
  • Bethesda, MD (US) (2019 - 2022)
  • Gaithersburg, MD (US) (2012 - 2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Anand Swaroop in Gene Therapy

Introduction

Anand Swaroop is a prominent inventor based in Gaithersburg, MD (US), known for his significant contributions to the field of gene therapy. With a total of seven patents to his name, he has made remarkable strides in developing treatments for various eye diseases.

Latest Patents

Among his latest patents are the RP2 and RPGR vectors for treating X-linked retinitis pigmentosa. These patents disclose adeno-associated virus (AAV) vectors that comprise a nucleotide sequence encoding RP2 or RPGR-ORF15, along with related pharmaceutical compositions. The patents also detail methods for treating or preventing X-linked retinitis pigmentosa, increasing photoreceptor numbers in the retina of mammals, and enhancing visual acuity. Additionally, he has developed methods and compositions for treating Leber congenital amaurosis, which include expression vectors, viral particles, and therapeutic methods aimed at improving visual function in patients suffering from eye diseases due to protein production failures.

Career Highlights

Anand Swaroop has had a distinguished career, working at esteemed institutions such as the University of Michigan and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has significantly impacted the understanding and treatment of genetic eye disorders.

Collaborations

Throughout his career, Anand has collaborated with notable colleagues, including Zhijian Wu and Suja Hiriyanna, contributing to advancements in gene therapy and ocular health.

Conclusion

Anand Swaroop's innovative work in gene therapy, particularly in treating retinal diseases, showcases his dedication to improving patient outcomes. His patents and collaborations reflect a commitment to advancing medical science and enhancing the quality of life for individuals with vision impairments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…